Inventor
BALASINGAM RADHAKRISHNAN
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes42%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides13%
C07DHeterocyclic compounds8%
A61MDevices for introducing media into, or onto, the body4%
PatentTitleYear
12,558,330Methods and compositions for treating edema refractory to oral diuretics202612,344,680Antifungal agents and uses thereof202512,329,731Methods and compositions for treating edema refractory to oral diuretics202512,150,923Methods and compositions for treating edema refractory to oral diuretics202412,146,006Synthesis of echinocandin antifungal agent202411,819,533Compositions and methods for the treatment of fungal infections202311,654,196Dosing regimens for echinocandin class compounds202311,524,980Synthesis of echinocandin antifungal agent202211,260,038Methods and compositions for treating edema refractory to oral diuretics202211,197,909Compositions and methods for the treatment of fungal infections2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to CIDARA THERAPEUTICS INC (4)· patent assignee history
2021–2026Based in US· patent location history
2022–2026Patents assigned to RESQ Pharmaceuticals LLC (4)· patent assignee history
2024–2025Patents assigned to NAPP PHARMACEUTICAL GROUP LTD (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CIDARA THERAPEUTICS INC | 4 | 2021–2023 |
| RESQ Pharmaceuticals LLC | 4 | 2022–2026 |
| NAPP PHARMACEUTICAL GROUP LTD | 2 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2021–2026 |